Abu‐Sayeef Mirza

634 total citations
39 papers, 342 citations indexed

About

Abu‐Sayeef Mirza is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Abu‐Sayeef Mirza has authored 39 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 8 papers in Genetics and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Abu‐Sayeef Mirza's work include CAR-T cell therapy research (12 papers), Lymphoma Diagnosis and Treatment (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Abu‐Sayeef Mirza is often cited by papers focused on CAR-T cell therapy research (12 papers), Lymphoma Diagnosis and Treatment (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Abu‐Sayeef Mirza collaborates with scholars based in United States, Switzerland and Australia. Abu‐Sayeef Mirza's co-authors include Sowmya Nanjappa, Rahul Mhaskar, Laurie Woodard, Rami S. Komrokji, Mohammad Hussaini, Jeffrey E. Lancet, Eric Padron, Etienne Léveillé, Jinming Song and Justin Swanson and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Abu‐Sayeef Mirza

35 papers receiving 337 citations

Peers

Abu‐Sayeef Mirza
Solange Mongoue‐Tchokote United States
Jane Jijun Liu United States
Deepam Pushpam India
Charlene M. McShane United Kingdom
Anthony Louder United States
Mehmet Hilmi Doğu Türkiye
Thuan V. Tran Vietnam
K. F. Tam Hong Kong
Ahsan Wahab United States
Andrew Hantel United States
Solange Mongoue‐Tchokote United States
Abu‐Sayeef Mirza
Citations per year, relative to Abu‐Sayeef Mirza Abu‐Sayeef Mirza (= 1×) peers Solange Mongoue‐Tchokote

Countries citing papers authored by Abu‐Sayeef Mirza

Since Specialization
Citations

This map shows the geographic impact of Abu‐Sayeef Mirza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abu‐Sayeef Mirza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abu‐Sayeef Mirza more than expected).

Fields of papers citing papers by Abu‐Sayeef Mirza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abu‐Sayeef Mirza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abu‐Sayeef Mirza. The network helps show where Abu‐Sayeef Mirza may publish in the future.

Co-authorship network of co-authors of Abu‐Sayeef Mirza

This figure shows the co-authorship network connecting the top 25 collaborators of Abu‐Sayeef Mirza. A scholar is included among the top collaborators of Abu‐Sayeef Mirza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abu‐Sayeef Mirza. Abu‐Sayeef Mirza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kamdar, Manali, Sairah Ahmed, Jeremy S. Abramson, et al.. (2025). CT-305: Optimizing Post-Chimeric Antigen Receptor (CAR) T-Cell Monitoring: Evidence Across Lisocabtagene Maraleucel (liso-cel) Pivotal Clinical Trials and Real-World Experience. Clinical Lymphoma Myeloma & Leukemia. 25. S1010–S1011.
3.
Hunter, Bradley D., Matthew A. Lunning, Sairah Ahmed, et al.. (2025). CRS or ICANS Are Rare Beyond 2 Weeks After Lisocabtagene Maraleucel Infusion: Data From Clinical Trials and the Real-World Setting. Transplantation and Cellular Therapy. 32(2). 171.e1–171.e12. 1 indexed citations
4.
Winter, Allison, Alex F. Herrera, Chaitanya Iragavarapu, et al.. (2024). Real-world outcomes of lisocabtagene maraleucel (liso-cel) in patients (pt) with Richter transformation (RT) from the Center for International Blood and Marrow Transplant Research (CIBMTR).. Journal of Clinical Oncology. 42(16_suppl). 7010–7010. 3 indexed citations
5.
6.
Léveillé, Etienne, Lai N. Chan, Abu‐Sayeef Mirza, Kohei Kume, & Markus Müschen. (2022). SYK and ZAP70 kinases in autoimmunity and lymphoid malignancies. Cellular Signalling. 94. 110331–110331. 17 indexed citations
7.
Bewersdorf, Jan Philipp, Abu‐Sayeef Mirza, Alyssa Grimshaw, et al.. (2021). Hypomethylating Agents and FLT3 Inhibitors As Maintenance Treatment for Acute Myeloid Leukemia and Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation–A Systematic Review and Meta-Analysis. Transplantation and Cellular Therapy. 27(12). 997.e1–997.e11. 23 indexed citations
8.
Swanson, Justin, et al.. (2021). Nutritional Literacy Among Uninsured Patients With Diabetes Mellitus: A Free Clinic Study. Cureus. 13(7). e16355–e16355. 8 indexed citations
9.
Mirza, Abu‐Sayeef, Ambuj Kumar, Hamza Hashmi, et al.. (2020). Incidence and Management of Effusions Before and After CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Large B Cell Lymphoma. Transplantation and Cellular Therapy. 27(3). 242.e1–242.e6. 7 indexed citations
10.
Woodard, Laurie, et al.. (2020). Prevalence and management of diabetes among the uninsured: A multicenter study in Tampa Bay, FL. Diabetes Research and Clinical Practice. 171. 108560–108560. 1 indexed citations
11.
Hashmi, Hamza, Abu‐Sayeef Mirza, Anuhya Kommalapati, et al.. (2020). Venous thromboembolism associated with CD19-directed CAR T-cell therapy in large B-cell lymphoma. Blood Advances. 4(17). 4086–4090. 34 indexed citations
12.
Swanson, Justin, et al.. (2020). Substance Use in Uninsured Cancer Survivors: A Multicenter Cross-Sectional Study of Free Clinics. Cureus. 12(8). e10083–e10083. 1 indexed citations
13.
Hashmi, Hamza, Abu‐Sayeef Mirza, Anuhya Kommalapati, et al.. (2020). Incidence and Management of Venous Thrombo-Embolism (VTE) Associated with CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy: A Single Institution Experience. Biology of Blood and Marrow Transplantation. 26(3). S265–S265. 1 indexed citations
14.
Mirza, Abu‐Sayeef, Bhagirathbhai Dholaria, Mohammad Hussaini, et al.. (2019). High-dose Therapy and Autologous Hematopoietic Cell Transplantation as Consolidation Treatment for Primary Effusion Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 19(9). e513–e520. 3 indexed citations
15.
Mirza, Abu‐Sayeef, et al.. (2019). Dermatologic care of uninsured patients managed at free clinics. Journal of the American Academy of Dermatology. 81(2). 433–437. 3 indexed citations
16.
Mirza, Abu‐Sayeef, et al.. (2018). Cave diving for a diagnosis: Disseminated histoplasmosis in the immunocompromised. IDCases. 12. 92–94. 2 indexed citations
17.
Mhaskar, Rahul, et al.. (2018). Chronic Disease Burden of the Homeless: A Descriptive Study of Student-Run Free Clinics in Tampa, Florida. Journal of Community Health. 44(2). 249–255. 28 indexed citations
18.
Hussaini, Mohammad, Abu‐Sayeef Mirza, Rami S. Komrokji, et al.. (2018). Genetic Landscape of Acute Myeloid Leukemia Interrogated by Next-generation Sequencing: A Large Cancer Center Experience. Cancer Genomics & Proteomics. 15(2). 121–126. 25 indexed citations
19.
Mirza, Abu‐Sayeef, Jeffrey E. Lancet, Kendra Sweet, et al.. (2017). A Phase II Study of CLAG Regimen Combined With Imatinib Mesylate for Relapsed or Refractory Acute Myeloid Leukemia. Clinical Lymphoma Myeloma & Leukemia. 17(12). 902–907. 7 indexed citations
20.
Fang, Bin, Melissa Hoffman, Abu‐Sayeef Mirza, et al.. (2015). Evaluating kinase ATP uptake and tyrosine phosphorylation using multiplexed quantification of chemically labeled and post-translationally modified peptides. Methods. 81. 41–49. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Solange Mongoue‐Tchokote Breakdown of academic impact, for papers by Jane Jijun Liu Breakdown of academic impact, for papers by Deepam Pushpam Breakdown of academic impact, for papers by Charlene M. McShane Breakdown of academic impact, for papers by Anthony Louder Breakdown of academic impact, for papers by Mehmet Hilmi Doğu Breakdown of academic impact, for papers by Thuan V. Tran Breakdown of academic impact, for papers by K. F. Tam Breakdown of academic impact, for papers by Ahsan Wahab Breakdown of academic impact, for papers by Andrew Hantel
Rankless by CCL
2026